Background and Purpose-Hematoma expansion in intracerebral hemorrhage is associated with higher morbidity and mortality. The computed tomography (CT) angiographic spot sign is highly predictive of expansion, but other morphological features of intracerebral hemorrhage such as fluid levels, density heterogeneity, and margin irregularity may also predict expansion, particularly in centres where CT angiography is not readily available. Methods-Baseline noncontrast CT scans from patients enrolled in the Predicting Hematoma Growth and Outcome in Intracerebral Hemorrhage Using Contrast Bolus CT (PREDICT) study were assessed for the presence of fluid levels and degree of density heterogeneity and margin irregularity using previously validated scales. Presence and grade of these metrics were correlated with the presence of hematoma expansion as defined by the PREDICT study on 24-hour followup scan. Results-Three hundred eleven patients were included in the analysis. The presence of fluid levels and increasing heterogeneity and irregularity were associated with 24-hour hematoma expansion (P=0.021, 0.003 and 0.049, respectively) as well as increases in absolute hematoma size. Fluid levels had the highest positive predictive value (50%; 28%-71%), whereas margin irregularity had the highest negative predictive value (78%; 71%-85). Noncontrast metrics had comparable predictive values as spot sign for expansion when controlled for vitamin K, antiplatelet use, and baseline National Institutes of Health Stroke Scale, although in a combined area under the receiver-operating characteristic curve model, spot sign remained the most predictive. Conclusions-Fluid levels, density heterogeneity, and margin irregularity on noncontrast CT are associated with hematoma expansion at 24 hours. These markers may assist in prediction of outcomes in scenarios where CT angiography is not readily available and may be of future help in refining the predictive value of the CT angiography spot sign. (Stroke. 2015;46:3111-3116.
Stroke
November 2015 I ntracerebral hemorrhage (ICH) accounts for 7% to 15% of all strokes, with a mortality rate approaching 40%, half within the first 2 days. 1 Multiple predictors of outcome after ICH have been determined, including ICH volume, 2 patient age, Glasgow Coma Scale on presentation, and intraventricular blood 3 ; recently, expansion of the hematoma, particularly in the early phase after onset, has also been associated with poor outcome. 4, 5 Approximately one third of patients have expansion of the hematoma, 4 suggesting that not all patients have the same expansion risk. Identifying patients at greatest risk of expansion could not only assist with prognostication but also provide opportunities to identify patients who may benefit from therapeutic intervention. 6 The spot sign, an area of contrast enhancement visible within a primary ICH on computed tomographic (CT) angiogram source images, is an important marker for hematoma expansion, and is associated with increased risk of hematoma growth [7] [8] [9] [10] [11] [12] [13] as well as with higher mortality and disability. 13 Although a relatively simple imaging technique, limitations include the need for iodinated contrast agents, potential for increased radiation exposure with the use of older-generation scanners and protocols, and reduced availability of CT angiography in smaller institutions and rural areas. In addition, the sensitivity for expansion in the Predicting Hematoma Growth and Outcome in Intracerebral Hemorrhage Using Contrast Bolus CT (PREDICT) study for spot-positive patients was 51%, suggesting that other methods for predicting hematoma expansion may be useful, particularly if combined with the spot sign to form a more sensitive predictive model.
Predictors of expansion that rely on noncontrast CT images may address some of these issues. Fluid-blood levels (also known as a blood sedimentation level) have been observed in patients with anticoagulant-associated ICH, and are thought to be associated with underlying coagulopathy. [14] [15] [16] Other noncontrast markers include the shape and density variation of the hematoma, with irregular margins and heterogeneous density being associated with expansion. 17 Validated scores to grade these markers have been developed. 17 Though not as sensitive as the spot sign, these three markers may be useful in predicting expansion in circumstances where CT angiography is unavailable or contraindicated, and may increase the predictive value of the spot sign when used together with vascular imaging. We hypothesized that these measures would predict expansion independently and together with the spot sign, and tested this using the images studied in the PREDICT data set. 13 We also tried to determine whether these noncontrast parameters might further refine the predictive value of the spot sign for hematoma expansion.
Subjects and Methods
The design of the PREDICT study has been previously published. 13 This was a multicentre, prospective observational cohort of consecutive patients with ICH; patients were aged ≥18, and had symptomatically and radiologically confirmed ICH with volumes of <100 mL. All patients presented within 6 hours of onset, and were excluded if they had a secondary cause of ICH, Glasgow Coma Scale <6, known renal impairment, modified Rankin Scale score of >3, or major comorbid or terminal illness. Patients were enrolled until February 27, 2012. The research protocol was approved by the research ethics board of the University of Calgary, Calgary, Alberta, Canada, and additional approval as required was given for each recruiting site if required by local ethics boards. All patients gave written informed consent as per requirements established by each local ethics body; where unable to do so, next of kin or legal guardian gave surrogate consent.
Patients underwent noncontrast CT scans at baseline and at 24 hours; all patients had CT angiography performed immediately after baseline scan. The details of image acquisition and processing have been described previously. 13 The relevant demographic and clinical details of each patient were also recorded. In this study, patients were excluded if they underwent surgical evacuation of the hematoma, received factor VIIa or other hemostatic therapy, or did not have baseline and follow-up noncontrast CT.
Noncontrast Image Analysis
Baseline noncontrast CT scans were assessed for density heterogeneity and margin irregularity of the hematoma as per the 5-point ordinal scales described and validated previously by Barras et al. 17 Scans were also evaluated for the presence of a fluid-blood level within the hematoma, defined as a change within the hematoma resulting in a linear interface between 2 discrete fluid densities ( Figure 1 ). Each scan was independently evaluated by 2 stroke neurologists (D.B. and A.D.). Discrepancies were defined as a disagreement over the presence of fluid-blood levels within a particular hematoma, or a difference of >1 grade in the scale for density heterogeneity or margin irregularity as used in the validation study. 17 All scans for which a discrepancy occurred were then reviewed by a stroke neuroradiologist (C.L.), blinded to previous scores, who provided a final interpretation and score.
Outcome Analysis
The primary outcome was significant hematoma expansion on follow-up CT, defined as an absolute growth in ICH of >6 mL, or relative enlargement of >33% when compared with baseline CT. This compares to outcome measures used previously, including the PREDICT trial. 3, 7, 13, 18 Secondary outcomes included the presence of a spot sign on CT angiography, as defined previously, 13 as well as absolute hematoma growth.
Statistical Analysis
All statistical analyses were performed using SAS version 9.2. Frequency tables and descriptive statistics were calculated to summarize variables, as appropriate. Interobserver agreement for fluid levels was calculated using the κ statistic, which measures the realized proportion of interobserver agreement beyond what can be obtained by chance (values >0.6 are associated with high interobserver Figure 1 . Representative scans showing the 5 grades of density heterogeneity (A) and margin irregularity (B). A5 demonstrates the presence of a fluid level. The full grading scale for density heterogeneity and margin irregularity is described by Barras et al. agreement); agreement for margin irregularity and density heterogeneity were measured using raw agreement scores (±1 grade on the 5-point scale for each metric) as previously described. 17 Associations between imaging metrics and expansion/spot sign presence were tested using Pearson χ 2 test. Differences in mean hematoma growth were tested using one-way ANOVA or Student t tests, as appropriate.
Sensitivity, specificity, and predictive values for each of the markers were calculated. For fluid levels, positivity or negativity of the marker were used as a positive and negative test, respectively; for density heterogeneity and margin irregularity, scores of 4 or 5 on the 5-point ordinal scale (reflecting the highest levels of heterogeneity and irregularity) were chosen as a positive test. This definition was agreed on by consensus, as hematomas with these scores were easily distinguishable by all observers from those with scores of ≤3 in these domains.
We assessed and compared predictive models using areas under receiver-operating characteristic (ROC) curves. A backward elimination regression procedure was used to identify variables which usefully modeled expansion. Area under the ROC curve was calculated for each of the noncontrast variables and for the spot sign, with bootstrapping used to refine the estimates. Using similar methods, a further model was developed to combine the markers to determine change in predictive value when added to the spot sign.
Results
Complete data were available on 356 individual patients. Of these, 12 received factor VIIa, 16 underwent surgical hematoma evacuation, and 17 were excluded from PREDICT for not meeting study criteria; this resulted in 311 patients eligible for analysis. Complete baseline clinical data were available for 286 patients (Table I in the online-only Data Supplement).
High interobserver agreement was seen for fluid levels (κ=0.7), whereas the observers scored heterogeneity and irregularity within±1 grade in 80.5% and 86.2% of cases, respectively. Relatively few (7.1%) of scans had positive fluid levels. Although most scans had low heterogeneity, many (27.7%) had heterogeneity scores of >3, and 52.3% showed irregularity scores of >3. Spot signs were seen in 38.2% of scans. All markers showed a statistically significant association with hematoma expansion on follow-up CT (Figure 2 ; Table II in the online-only Data Supplement). Fluid levels were associated with hematoma expansion in 50% of cases where present; the spot sign was associated with expansion in 52.3% of cases where present, but was much more common than fluid levels. Increasing heterogeneity and irregularity were likewise associated with a higher risk of expansion. The 3 noncontrast markers were likewise associated with the presence of the CT angiography spot sign on source images and with absolute hematoma growth at 24 hours ( Figure 3 ; Table  III in the online-only Data Supplement).
Sensitivities, specificities, and positive and negative predictive values are shown in Table compared with those calculated for the spot sign in the PREDICT study. 13 Margin irregularity (grade 4-5) had the greatest sensitivity for hematoma expansion when compared with the other markers; in contrast, the presence of a fluid level was the most specific. However, the spot sign had the highest positive and negative predictive values for hematoma expansion at 24 hours. The use of a vitamin K antagonist or antiplatelet at baseline, as well as an increased baseline National Institutes of Health Stroke Scale, were associated with hematoma expansion and the presence of all imaging markers.
The area under the ROC curve was calculated for each marker, with bootstrapping used to refine the estimate (Table) . Spot sign remained the most predictive (area under the ROC curve=0.76; 95% CI, 0.69-0.82). However, the other markers had roughly similar area under the ROC curve values when the same variables were included in the model. When combined together, however, only the spot sign remained predictive in a model accounting for all 4 variables. 
Discussion
These data show that margin irregularity, density heterogeneity, and fluid levels are associated with hematoma expansion at 24 hours, similar to the spot sign. They are easy to score, with minimal training required, and relatively high interobserver agreement. They are also predictive of the presence of a spot sign, and of increased mean hematoma growth at 24 hours. However, they are less sensitive and specific than the spot sign, which remains the most predictive marker for hematoma expansion.
We theorize that these markers are surrogates for a similar phenomenon as the spot sign: ongoing, active bleeding within the hematoma. The spot sign is likely active extravasation of contrast in areas of ongoing bleeding, 19 whereas these markers may be more indirect. Density heterogeneity and fluid levels may represent extravasated blood at different time points, suggestive of a dynamic process; heterogeneity has also been theorized to represent multifocality of the bleed. 17 Similarly, margin irregularity may reflect multiple origins or bleeding sources within the hematoma, which would be more likely to progress along multiple tracks and present with an irregular edge. 17 All 3 markers had a comparable reliability using ROC analysis, suggesting all would have comparative efficacy in determining risk of expansion in a model accounting for previous antiplatelet or Vitamin K antagonist use and baseline National Institutes of Health Stroke Scale. The 3 noncontrast markers showed a similar ROC value when compared with the spot sign, suggesting that these markers could act as a surrogate for the presence of the spot sign when a CT angiogram is not practical or available. However, in a model combining each of the markers, the predictive value of the spot sign was not significantly altered when the noncontrast markers were added. This would agree with our findings concerning the predictive values, sensitivity, and specificity; overall, the spot sign was the most reliable and predictive measure for expansion, although noncontrast markers performed reasonably well. This suggests that CT angiography spot sign remains the most useful predictor of expansion, but in scenarios where it is not available, the others may be able to predict expansion, albeit with less sensitivity.
Our study confirms the use of previous work on margin irregularity and density heterogeneity as predictors of hematoma expansion, 5 using a large, multicentre cohort of consecutive patients. We also propose fluid levels as a predictor for expansion. We confirm the interrater agreement of these markers, suggesting that they can be reliably used. However, there are some limitations to the study. All analysis is based on axial images; it is possible that coronal or sagittal views may alter the visual characteristics of these markers. The median time from onset to scan in our group was 137 minutes, which may have enriched the sample with patients at highest risk of expansion. Finally, we did not examine the impact of these markers on clinical outcomes such as mortality and disability as we did not have complete clinical followup for all patients.
Our study shows that markers on noncontrast CT are predictive of hematoma expansion. They may be useful in future studies to help determine patients at highest risk of hematoma expansion, offering opportunities for targeted therapeutic intervention, and may be of help in scenarios where access to CT angiography for determination of spot status is limited. Our results require external validation to confirm the use of these markers for trial selection, prognostication, and to develop clinical prediction rules for hematoma expansion.
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